Remdesivir: McEnany Says Patients Won’t Pay, Hospitals Will Profit from Gilead Drug

White House Press Secretary Kayleigh McEnany said that “patients will be very unlikely to see the cost” of Gilead’s remdesivir under the new pricing model and that “hospitals will profit” by releasing patients early. She made the remarks during a press briefing at the White House on Monday, June 29, in Washington, D.C.

Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm

QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter: https://bit.ly/2FJ0oQZ
Email us at [email protected]

QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.

source